Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ZYNOL-150 TABLET 150 MG - HSA Drug Approval Details

Approvals/HSA/ZYNOL-150 TABLET 150 MG

Approved

THERAPEUTIC

ZYNOL-150 TABLET 150 MG

MICRO LABS LTD (INDIA)🇸🇬 Health Sciences Authority

Approval Date: Oct 10, 1998
Approval ID: fd55666fff39af3b
Company: MICRO LABS LTD (INDIA)
Type: Therapeutic

Approval Details

Approval Id: fd55666fff39af3b
Drug Name: ZYNOL-150 TABLET 150 MG
Product Name: ZYNOL-150 TABLET 150 MG
Approval Number: SIN10248P
Approval Date: 1998-10-10
Registrant: NAINA MOHAMED & SONS PRIVATE LIMITED
Licence Holder: NAINA MOHAMED & SONS PRIVATE LIMITED
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: TABLET, FILM COATED
Route Of Administration: ORAL
Atc Code: A02BA02
Atc Item Name: ranitidine
Pharma Manufacturer Name: NAINA MOHAMED & SONS PRIVATE LIMITED

Active Ingredients

RANITIDINE HCl EQV RANITIDINE

150 mg

RANITIDINE HCL EQV RANITIDINE

150 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Oct 10, 1998

Approval ID

fd55666fff39af3b

Type

Therapeutic

Back to HSA Approvals